Iraq vs Netherlands: Prevalence of current tobacco use
Prevalence of current tobacco use over time
- Iraq
- Netherlands
How they compare
Netherlands currently reports 20.5% against 20.1% in Iraq, a difference of 0.4%.
Across all 9 years both countries report, Netherlands has been ahead every year.
Iraq ranks 79th and Netherlands ranks 77th of 166 countries.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iraq | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 22.3% | 31.9% | 9.5% | Netherlands |
| 2010s | 21.1% | 26.4% | 5.3% | Netherlands |
| 2020s | 20.2% | 21.3% | 1.1% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, Iraq or Netherlands?
- Netherlands, at 20.5% against 20.1% in Iraq as of 2024.
- What is the difference in prevalence of current tobacco use between Iraq and Netherlands?
- 0.4%, with Netherlands ahead.
- How many years of comparable data are there for Iraq and Netherlands?
- 9 years are reported by both, from 2000 to 2024.
- How do Iraq and Netherlands rank globally for prevalence of current tobacco use?
- Iraq ranks 79th and Netherlands ranks 77th of 166 countries.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use (% of adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.